Market Tracker

10/31 7:05pm ET

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

5.14
Data as of Oct 31
 -0.08 / -1.53%
Today’s Change
3.81
Today|||52-Week Range
7.22
-15.32%
Year-to-Date
No recent news for Nymox Pharmaceutical Corp.

Today’s Trading

Previous close5.22
Today’s open5.24
Day’s range5.12 - 5.24
Volume16,922
Average volume (3 months)90,852
Market cap$184.8M
Dividend yield--
Data as of 3:59pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)+39.13%
Earnings growth (this year)-14.29%
Earnings growth (next 5 years)--
Revenue growth (last year)+9.32%
P/E ratioNM
Price/Sales61.71
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ELTPElite Pharmaceutical...+0.00+0.78%
CPRXCatalyst Pharmaceuti...+0.23+8.39%
ZGNXZogenix Inc-0.01-0.78%
AKAOAchaogen Inc+0.41+4.02%
Data as of 4:14pm ET, 10/31/2014

Financials

Next reporting dateNovember 14, 2014
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$3.4M
Annual profit (last year)-$4.9M
Net profit margin-146.13%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer
André Monette
Corporate headquarters
Saint-Laurent, Quebec

Forecasts